Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 1/20 | 0.64 |
| ▸ | MINK1 | Q8N4C8 | 1/20 | 0.64 |
| ▸ | CYSLTR1 | Q9Y271 | 3/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.37 |
| ▸ | PLA2G4A | P47712 | 6/20 | 0.35 |
| ▸ | EP300 | Q09472 | 3/20 | 0.35 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28475221 | 0.93 | ERBB2 (0.60) | ERBB2MINK1CYSLTR1FFAR1EP300 | |
| SCHEMBL28475225 | 0.93 | ERBB2 (0.60) | ERBB2MINK1CYSLTR1FFAR1EP300 | |
| SCHEMBL6582279 | 0.90 | ERBB2 (0.68) | ERBB2MINK1FFAR1 | |
| SCHEMBL6582276 | 0.90 | ERBB2 (0.68) | ERBB2MINK1FFAR1 | |
| SCHEMBL22398061 | 0.88 | ERBB2 (0.66) | ERBB2MINK1FFAR1 | |
| SCHEMBL22398264 | 0.88 | ERBB2 (0.66) | ERBB2MINK1FFAR1 | |
| SCHEMBL22397958 | 0.88 | ERBB2 (0.66) | ERBB2MINK1FFAR1 | |
| SCHEMBL5385106 | 0.88 | ERBB2 (0.66) | ERBB2MINK1FFAR1 | |
| SCHEMBL5385109 | 0.88 | ERBB2 (0.66) | ERBB2MINK1FFAR1 | |
| SCHEMBL28900623 | 0.88 | ERBB2 (0.66) | ERBB2MINK1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3704111-A1 | HETEROCYCLIC MITOCHONDRIAL ACTIVITY INHIBITORS AND USES THEREOF | Université de Montréal (CA) | 2020-09-09 | — | — | EP | disclosed |